[1] TIAN Y, LIU Q, WU K, et al. Meta-analysis comparing the efficacy of nedaplatin-based regimens between squamous cell and non-squamous cell lung cancers[J]. Oncotarget, 2017, 8(37): 62330. doi: 10.18632/oncotarget.17499
[2] TENG JP, YANG ZY, ZHU YM, et al. Gemcitabine and cisplatin for treatment of lung cancer in vitro and vivo[J]. Eur Rev Med Pharmacol Sci, 2018, 22(12): 3819.
[3] LI CH, LIU MY, LIU W, et al. Randomized control study of nedaplatin or cisplatin concomitant with other chemotherapy in the treatment of advanced non-small cell lung cancer[J]. Asian Pac J Cancer Prev, 2014, 15(2): 731. doi: 10.7314/APJCP.2014.15.2.731
[4] 袁学东, 杨国玉, 张健英, 等. 奈达铂联合化疗与卡铂联合化疗对晚期非小细胞肺癌疗效与不良反应的Meta分析[J]. 四川医学, 2017, 38(3): 253.
[5] TOFFALORIO F, SANTARPIA M, RADICE D, et al. 5'-nucleotidase cN-Ⅱ emerges as a new predictive biomarker of response to gemcitabine/platinum combination chemotherapy in non-small cell lung cancer[J]. Oncotarget, 2018, 9(23): 16437. doi: 10.18632/oncotarget.24505
[6] YANG JJ, ZHOU Q, LIAO RQ, et al. Nedaplatin/gemcitabine versus carboplatin/gemcitabine in treatment of advanced non-small cell Lung cancer: A randomized clinical trial[J]. Chin J Cancer Res, 2012, 24(2): 97. doi: 10.1007/s11670-012-0097-8
[7] 张晶, 陈群, 柯明耀, 等. 奈达铂联合吉西他滨与顺铂联合吉西他滨一线治疗晚期肺鳞状细胞癌随机对照临床研究[J]. 国际肿瘤学杂志, 2017, 44(1): 15. doi: 10.3760/cma.j.issn.1673-422X.2017.01.004
[8] 周宇, 何立香, 黄仕思. 吉西他滨联合奈达铂治疗晚期肺鳞癌疗效与安全性临床观察[J]. 中华肿瘤防治杂志, 2017, 24(15): 1083.
[9] WANG H, ZHU XL, HUANG J, et al. Nedaplatin sensitization of cisplatin-resistant human non-small cell lung cancer cells[J]. Oncol Lett, 2016, 11(4): 2566. doi: 10.3892/ol.2016.4276
[10] SCAGLIOTTI GV, PARIKH P, VON PAWEL J, et al. Phase Ⅲ study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer[J]. J Clin Oncol, 2008, 26(21): 3543. doi: 10.1200/JCO.2007.15.0375
[11] 陈永倖, 符诒慧, 蒙冲. 吉西他滨联合奈达铂一线治疗晚期非小细胞肺癌的临床疗效及安全性评价[J]. 临床内科杂志, 2019, 36(7): 476. doi: 10.3969/j.issn.1001-9057.2019.07.013
[12] 程弯弯, 孔君, 杨雪, 等. 联合SCUBE1、D-二聚体在急性肺血栓栓塞症诊断中的应用[J]. 南京医科大学学报, 2018, 38(9): 1229.
[13] 刘倩. 非小细胞肺癌患者凝血功能分析[J]. 世界最新医学信息文摘, 2020, 20(77): 166. doi: 10.3969/j.issn.1671-3141.2020.77.092
[14] 胡泓, 王帷, 潘虹, 等. 纤维蛋白原和D-二聚体与老年晚期非小细胞癌化疗疗效和无进展生存期的相关性[J]. 中国老年学杂志, 2018, 38(3): 589. doi: 10.3969/j.issn.1005-9202.2018.03.033
[15] 谢黎黎, 江启安, 唐文娟. 血浆D-二聚体水平与晚期食管鳞癌化疗疗效及预后的相关性研究[J]. 蚌埠医学院学报, 2019, 44(4): 452.